Metraipolis › archive › dc_2bc27ebedb23
Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis — Europe PMC PMID:41709229
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41709229
- DOI
- 10.1186/s13044-[numero omesso]-x
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-05T16:14:42.956Z
- SHA-256 of the archived text
253ce5fcb0726d00de5b8afee07cd3714b4b881e2e26afb332a1f141e1319066- Stable URL of this page
https://metraipolis.com/documento/dc_2bc27ebedb23
How to cite
Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis — Europe PMC PMID:41709229 — Europe PMC (en), https://europepmc.org/article/MED/41709229 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2bc27ebedb23 (Metraipolis archive dc_2bc27ebedb23, sha256 253ce5fcb0726d00de5b8afee07cd3714b4b881e2e26afb332a1f141e1319066)
BibTeX
@misc{dc2bc27ebedb23,
title = {Safety and efficacy of peptide receptor radionuclide therapy for advanced medullary thyroid cancer: a systematic review and meta-analysis — Europe PMC PMID:41709229},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41709229},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2bc27ebedb23; sha256 253ce5fcb0726d00de5b8afee07cd3714b4b881e2e26afb332a1f141e1319066},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41709229. Agents can read the archived copy with the MCP tool read_document.